Effects of coenzyme Q and creatine supplementation on brain energy metabolism in rats exposed to chronic cerebral hypoperfusion

Current Alzheimer Research

Volumn 8, Issue 8, 2011, Pages 868-875

  Horeck, Jaromír ^a   Gvozdjáková, Anna ^b   Kucharská, Jarmila ^b   Obrenovich, Mark E ^c   Palacios, Hector H ^d   Li, Yi ^e   Vančová, O'ga ^b   Aliev, Gjumrakch ^f,g  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^b Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^c CLEVELAND STATE UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f University of Atlanta   (United States)

^g GALLY International Biomedical Research Consulting LLC   (United States)

Author keywords

31p mrs; Coenzyme q10; Creatine; Endogenous antioxidants; Oxphos; Three vessel occlusion; Vascular dementia

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; BETA TOCOPHEROL; COENZYME Q 9; CREATINE CITRATE; GAMMA TOCOPHEROL; LI Q SORB; NEUROPROTECTIVE AGENT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UBIQUINONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN MITOCHONDRION; BRAIN OXYGEN CONSUMPTION; CONTROLLED STUDY; DEMENTIA; ENERGY METABOLISM; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; MALE; MITOCHONDRIAL RESPIRATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; CEREBRAL CORTEX; CHRONIC DISEASE; CITRATES; CREATINE; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; HYPOXIA-ISCHEMIA, BRAIN; MALE; MICRONUTRIENTS; OXIDATIVE STRESS; PERFUSION; RATS; RATS, WISTAR; UBIQUINONE;

EID: 82055162842     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720511798192727     Document Type: Article

References (44)

1. de la Torre JC. Critical threshold cerebral hypoperfusion causes Alzheimer's disease? Acta Neuropathol 98:1-8 (1999).
2. Aliev G, Palacios HH, Walrafen B, Lipsitt AE, Obrenovich ME, Morales L. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease. Int J Biochem Cell B 41: 1989-2004 (2009).
3. Kogure K, Arai H, Abe K, Nakano M. Free-Radical Damage of the Brain Following Ischemia. Prog Brain Res 63: 237-59 (1985).
4. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cerebr Blood F Met 21: 2-14 (2001).
5. Jenkins LW, Povlishock JT, Lewelt W, Miller JD, Becker DP. The role of postischemic recirculation in the development of ischemic neuronal injury following complete cerebral ischemia. Acta Neuropathol 55: 205-20 (1981).
6. Mori T, Asano T, Matsui T, Muramatsu H, Ueda M, Kamiya T, et al. Intraluminal increase of superoxide anion following transient focal cerebral ischemia in rats. Brain Res 816: 350-7 (1999).
7. Horecký J, Bačiak L, Vančová O, Wimmerova S, Kašparová S. Effects of transient ischemia on rat brain energy metabolism assessed in vivo by 31P MRS and in vitro by mitochondrial OXPHOS. Biochim Biophys Acta - Bioenergetics S: 178-179 (2006).
8. Horecký J, Bačiak L, Kašparová S, Pacheco G, Aliev G, Vančová O. Minimally invasive surgical approaches for three-vessel occlusion as a model of vascular dementia in the rat - brain bioenergetics assay. J Neurol Sci 283(1-2): 178-81 (2009).
9. Sarma JS, Ikeda S, Fischer R, Maruyama Y, Weishaar R, Bing RJ. Biochemical and contractile properties of heart muscle after prolonged alcohol administration. J Mol Cell Cardiol 8: 951-72 (1976).
10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-75 (1951).
11. Lang JK, Gohil K, Packer L. Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. Anal Biochem 157: 106-16 (1986).
12. Kucharska J, Gvozdjakova A, Mizera S, Braunova Z, Schreinerova Z, Schramekova E, et al. Participation of coenzyme Q10 in the rejection development of the transplanted heart: a clinical study. Physiol Res 47: 399-404 (1998).
13. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-8 (1979).
14. Janero DR, Burghardt B. Thiobarbituric acid-reactive malondialdehyde formation during superoxide-dependent, iron-catalyzed lipid peroxidation: influence of peroxidation conditions. Lipids 24: 125-31 (1989).
15. Horecký J, Aliev G, Gvozdjáková A, Kucharská J, Vančová O. Preventive and therapeutic coenzyme Q10 supplementation in rat subjected to cerebrovascular ischemia-reperfusion injury. Current Neurobiology 1(1): 30-6 (2010).
16. Aliev G, Smith MA, de la Torre JC, Perry G. Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion 4: 649-63 (2004).
17. de la Torre JC, Fortin T, Park GA, Pappas BA, Richard MT. Brain blood flow restoration 'rescues' chronically damaged rat CA1 neurons. Brain Res 623: 6-15 (1993).
18. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 11: 491-8 (1982).
19. Schmidt-Kastner R, Freund TF. Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 40: 599-636 (1991).
20. Sims NR, Pulsinelli WA. Altered mitochondrial respiration in selectively vulnerable brain subregions following transient forebrain ischemia in the rat. J Neurochem 49:1367-74 (1987).
21. Sciamanna MA, Lee CP. Ischemia/reperfusion-induced injury of forebrain mitochondria and protection by ascorbate. Arch Biochem Biophys 305: 215-24 (1993).
22. Aliev G, Gasimov E, Obrenovich ME, Fischbach K, Shenk JC, Smith MA, et al. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease. Vasc Health Risk Manag 4: 721-30 (2008).
23. Halliwell B, Gutteridge JMC. Oxygen Radicals and the Nervous- System. Trends Neurosci 8: 22-6 (1985).
24. Aliev G, Obrenovich ME, Reddy VP, Shenk JC, Moreira PI, Nunomura A, et al. Antioxidant Therapy in Alzheimer's Disease: Theory and Practice. Mini-Rev Med Chem 8:1395-406 (2008).
25. Candelario-Jalil E, Mhadu NH, Al-Dalain SM, Martinez G, Leon OS. Time course of oxidative damage in different brain regions following transient cerebral ischemia in gerbils. Neurosci Res 41: 233-41 (2001).
26. Frank L, Massaro D. Oxygen-Toxicity. Am J Med 69:117-26 (1980).
27. Ames BN, Shigenaga MK, Hagen TM. Oxidants, Antioxidants, and the Degenerative Diseases of Aging. P Natl Acad Sci USA 90: 7915-22 (1993).
28. Shenk JC, Liu J, Fischbach K, Xu K, Puchowicz M, Obrenovich ME, et al. The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease. J Neurol Sci 283: 199-206 (2009).
29. Aliev G. Oxidative stress induced-metabolic imbalance, mitochondrial failure, and cellular hypoperfusion as primary pathogenetic factors for the development of Alzheimer disease which can be used as a alternate and successful drug treatment strategy: past, present and future. CNS Neurol Disord Drug Targets 10: 147-8 (2011).
30. Aliev G, Palacios HH, Lipsitt AE, Fischbach K, Lamb BT, Obrenovich ME, et al. Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease. Neurotox Res 16: 293-305 (2009).
31. Obrenovich ME, Li Y, Parvathaneni K, Yendluri BB, Palacios HH, Leszek J, et al. Antioxidants in health, disease and aging. CNS Neurol Disord Drug Targets 10: 192-207 (2011).
32. Palacios HH, Yendluri BB, Parvathaneni K, Shadlinski VB, Obrenovich ME, Leszek J, et al. Mitochondrion-specific antioxidants as drug treatments for Alzheimer disease. CNS Neurol Disord Drug Targets 10: 149-62 (2011).
33. Crane FL, Navas P. The diversity of coenzyme Q function. Molecular Aspects of Medicine 1997;18:S1-S6 (1997).
34. James AM, Smith RAJ, Murphy MP. Antioxidant and prooxidant properties of mitochondrial Coenzyme Q. Archives of Biochemistry and Biophysics 423:47-56 (2004).
35. Turunen M, Olsson J, Dallner G. Metabolism and function of coenzyme Q. Biomembranes1660:171-99 (2004).
36. Vancová O, BaČiak L, Kašparová S, Kucharska J, Palacios HH, Horecký J, Aliev G. In vivo and in vitro assessment of brain bioenergetics in aging rats. J Cell Mol Med 14: 2667-74 (2010).
37. Obrenovich ME, Nair NG, Beyaz A, Aliev G, Reddy VP. The role of polyphenolic antioxidants in health, disease, and aging. Rejuvenation Res 13: 631-43 (2010).
38. Aliev G, Liu J, Shenik JC, Fischbach K, Pacheco GJ, Chen SG, et al. Neuronal mitochondrial amelioration by feeding acetyl-Lcarnitine and lipoic acid to aged rats. J Cell Mol Med 13(2): 320-33 (2009).
39. Zhang YY, Aberg F, Appelkvist EL, Dallner G, Ernster L. Uptake of Dietary Coenzyme-Q Supplement Is Limited in Rats. J Nutr 125: 446-53 (1995).
40. Zhang YY, Turunen M, Appelkvist EL. Restricted uptake of dietary coenzyme Q is in contrast to the unrestricted uptake of alphatocopherol into rat organs and cells. J Nutr 126: 2089-97 (1996).
41. Kwong LK, Kamzalov S, Rebrin I, Bayne ACV, Jana CK, Morris P, et al. Effects of coenzyme Q(10) administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat. Free Radical Bio Med 33: 627-38 (2002).
42. Snow RJ, Murphy RM. Creatine and the creatine transporter: A review. Molecular and Cellular Biochemistry 224: 169-81 (2001).
43. Persky AM, Brazeau GA, Hochhaus G. Pharmacokinetics of the dietary supplement creatine. Clin Pharmacokinet 42: 557-74 (2003).
44. Ohtsuki S, Tachikawa M, Takanaga T, Shimizu H, Watanabe TM, Hosoya K, et al. The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain. J Cerebr Blood F Met 22: 1327-35 (2002).